alpha-aminopyridine has been researched along with Adrenal Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alarcon, S; Collins, J; Doroshow, JH; Kinders, RJ; Kummar, S; Lee, MJ; Park, SR; Pfister, T; Piekarz, R; Speranza, G; Steinberg, SM; Trepel, JB; Wang, L; Wright, JJ | 1 |
Lee, M; Pellegata, NS; Reubi, JC; Waser, B | 1 |
Eisenbrand, G; Habs, M; Shubik, P | 1 |
1 trial(s) available for alpha-aminopyridine and Adrenal Cancer
Article | Year |
---|---|
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Aminopyridines; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Cohort Studies; Colorectal Neoplasms; Endothelial Cells; Female; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Morpholines; Neoplasms; Oxazines; Pheochromocytoma; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Thyroid Neoplasms | 2013 |
2 other study(ies) available for alpha-aminopyridine and Adrenal Cancer
Article | Year |
---|---|
Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aminopyridines; Animals; Apoptosis; Cell Proliferation; Cell Survival; Female; Gastrointestinal Agents; Gene Knockdown Techniques; Humans; Imidazoles; Male; Morpholines; Neurites; PC12 Cells; Pheochromocytoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolines; Rats; Receptors, G-Protein-Coupled; Receptors, Gastrointestinal Hormone; RNA Interference; Secretin; Signal Transduction; Transcription, Genetic | 2012 |
Carcinogenicity of methapyrilene hydrochloride, mepyramine hydrochloride, thenyldiamine hydrochloride, and pyribenzamine hydrochloride in Sprague-Dawley rats.
Topics: Adenoma; Adrenal Gland Neoplasms; Aminopyridines; Animals; Dose-Response Relationship, Drug; Female; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Methapyrilene; Neoplasms, Experimental; Pyridines; Pyrilamine; Rats; Structure-Activity Relationship; Tripelennamine | 1986 |